Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Everest Organics is an India-based public pharmaceutical company focused on the development and manufacture of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and related contract development and manufacturing services. The company operates a manufacturing site in Sadasivpet, Telangana and markets a portfolio of more than 30 APIs and 30-plus intermediates, with a particular presence in proton pump inhibitor and other small-molecule generic API categories. Everest Organics also offers CRAMS/CDMO/CMO services including co-development and custom synthesis for pharmaceutical customers. Its products are supplied to domestic and international pharmaceutical markets, and the company has highlighted USFDA-inspected operations and DMF-supported API commercialization capabilities. Overall, Everest Organics is best characterized as a commercial-stage small-molecule API and intermediates manufacturer rather than a therapeutic biotech innovator.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Everest Organics.